Healthcare -
Biotechnology - NASDAQ - US
$ 10.27
-2.38 %
$ 433 M
Market Cap
-3.4
P/E
URGN - OTHER CURRENT LIABILITIES
Other Current Liabilities URGN - UroGen Pharma Ltd.
24.7 M
LAST VALUE
22.00%
2 YEAR CAGR
21.85%
5 YEAR CAGR
66.59%
10 YEAR CAGR